Company Registration No. 14481893 (England and Wales)
HIP AND KNEE HEALTH LTD
UNAUDITED FINANCIAL STATEMENTS
31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
LITHGOW PERKINS LLP
Chartered Accountants
Crown Chambers
Princes Street
Harrogate
HIP AND KNEE HEALTH LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
HIP AND KNEE HEALTH LTD
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
4
7,847
4,284
Cash at bank and in hand
37,198
33,374
45,045
37,658
Creditors: amounts falling due within one year
5
(37,490)
(12,963)
Net current assets
7,555
24,695
Capital and reserves
Called up share capital
6
2
2
Profit and loss reserves
7,553
24,693
Total equity
7,555
24,695

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 5 December 2025 and are signed on its behalf by:
C J Lodge
Director
Company registration number 14481893 (England and Wales)
HIP AND KNEE HEALTH LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information

Hip and Knee Health Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Crown Chambers, Princes Street, HARROGATE, HG1 1NJ.

1.1
Reporting period

These accounts are for the year ended 31 March 2025. The comparative information is for the period commencing 14 November 2022 and ending 31 March 2024. The comparative data is therefore not entirely comparable.

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

The financial statements are prepared on the going concern basis. Management has assessed the company’s ability to continue as a going concern using all available information and has concluded that the company will continue to trade for the foreseeable future. true

1.4
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

HIP AND KNEE HEALTH LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 3 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

HIP AND KNEE HEALTH LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.9
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
7,847
4,284
5
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
28,050
5,800
Other creditors
9,440
7,163
37,490
12,963
HIP AND KNEE HEALTH LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
6
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
0
2
-
0
2
Ordinary 'A' shares of £1 each
1
0
1
-
0
Ordinary 'B' shares of £1 each
1
0
1
-
0
2
2
2
2

During the year, there was a re-conversion of shares, whereby the 2 £1 ordinary shares were converted into 1 £1 ordinary 'A' share and 1 £1 ordinary 'B' share.

2025-03-31 2024-04-01 false false false 05 December 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity C J Lodge Dr L A Johnson 14481893 2024-04-01 2025-03-31 14481893 2025-03-31 14481893 2024-03-31 14481893 core:CurrentFinancialInstruments 2025-03-31 14481893 core:CurrentFinancialInstruments 2024-03-31 14481893 core:ShareCapital 2025-03-31 14481893 core:ShareCapital 2024-03-31 14481893 core:RetainedEarningsAccumulatedLosses 2025-03-31 14481893 core:RetainedEarningsAccumulatedLosses 2024-03-31 14481893 core:ShareCapitalOrdinaryShareClass1 2025-03-31 14481893 core:ShareCapitalOrdinaryShareClass1 2024-03-31 14481893 core:ShareCapitalOrdinaryShareClass2 2025-03-31 14481893 core:ShareCapitalOrdinaryShareClass2 2024-03-31 14481893 core:ShareCapitalOrdinaryShareClass3 2025-03-31 14481893 core:ShareCapitalOrdinaryShareClass3 2024-03-31 14481893 core:ShareCapitalOrdinaryShares 2025-03-31 14481893 core:ShareCapitalOrdinaryShares 2024-03-31 14481893 bus:Director1 2024-04-01 2025-03-31 14481893 2022-11-14 2024-03-31 14481893 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 14481893 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 14481893 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 14481893 bus:OrdinaryShareClass1 2025-03-31 14481893 bus:OrdinaryShareClass1 2024-03-31 14481893 bus:OrdinaryShareClass2 2025-03-31 14481893 bus:OrdinaryShareClass2 2024-03-31 14481893 bus:OrdinaryShareClass3 2025-03-31 14481893 bus:OrdinaryShareClass3 2024-03-31 14481893 bus:AllOrdinaryShares 2025-03-31 14481893 bus:AllOrdinaryShares 2024-03-31 14481893 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 14481893 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 14481893 bus:FRS102 2024-04-01 2025-03-31 14481893 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 14481893 bus:Director2 2024-04-01 2025-03-31 14481893 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP